Erratum: Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab. (Cancer 2014 120 (1780-1786))

S. Pant, L. K. Martin, S. Geyer, L. Wei, K. Van Loon, N. Sommovilla, M. Zalupski, R. Iyer, D. Fogelman, A. H. Ko, T. Bekaii-Saab

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab. (Cancer 2014 120 (1780-1786))'. Together they form a unique fingerprint.